INVESTOR PRESENTATION AVAILABILITY NOTICE: “HALF YEAR 2021 RESULTS PRESENTATION”

INVESTOR PRESENTATION AVAILABILITY NOTICE: YEAR 2021

Verdellino (BG), 16 September 2021

Fine Foods Half Year 2021 is publicly available on www.finefoods.it, in the Investor relations / Presentationssection.

***

This press release is available on the Fine Foods website www.finefoods.it,in the Investor Relations/Press Releases section.

***

Fine Foods & Pharmaceuticals N.T.M. S.p.A., listed on the STAR segment of the MTA of Borsa Italiana, is an independent Italian Contract Development & Manufacturing Organisation (CDMO). It develops and manufactures contract products for the pharmaceutical and nutraceutical industry; the Fine Foods Group is also active in the cosmetics, biocides and medical devices industries with its recent acquisition of Pharmatek- PMC.

Founded in 1984, from a pharmaceutical and nutraceutical synergy, Fine Foods has been pursuing quality and

cent CAGR over the last decade, it is a growing and future-oriented company.

The sustainability of the business model and the holistic approach to ESG, together with product innovation, are drivers that will allow the Group to fully develop its intrinsic potential.

	***
For information:
Fine Foods & Pharmaceuticals N.T.M. S.p.A.	CDR Communication
Investor Relations	Media Relations
tel. [phone]	Marianna Tremolada
[e-mail]	[e-mail]

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Sede legale: 24040 Zingonia-Verdellino (BG) via Berlino, 39 - tel. [phone] fax [phone] - www.finefoods.it - E-mail:[e-mail]

Cap. Soc. euro 22.770.445,02 i.v. - P.IVA IT 09320600969 - Registro Imprese e Cod.Fisc. 09320600969